标题
Antipsychotic treatment modulates glutamate transport and NMDA receptor expression
作者
关键词
Animal model, Aripiprazole, Antipsychotic, Dopamine, Glutamate, Schizophrenia, Serotonin
出版物
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume 264, Issue S1, Pages 67-82
出版商
Springer Nature
发表日期
2014-09-11
DOI
10.1007/s00406-014-0534-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
- (2013) Joanna M. Wierońska et al. BEHAVIOURAL BRAIN RESEARCH
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia
- (2013) Evangelos Papanastasiou et al. BRITISH JOURNAL OF PSYCHIATRY
- Therapeutic targets in major psychiatric disorders revisited
- (2013) Andrea Schmitt et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- AMPA receptor positive allosteric modulators: a patent review
- (2013) Bernard Pirotte et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia
- (2013) Pierre Sokoloff et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Kainate Receptors in Health and Disease
- (2013) Juan Lerma et al. NEURON
- NMDA receptors in nervous system diseases
- (2013) Qiang Zhou et al. NEUROPHARMACOLOGY
- Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis
- (2013) Andrea de Bartolomeis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia
- (2013) Dan Shan et al. SCHIZOPHRENIA RESEARCH
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
- (2013) Tomiki Sumiyoshi et al. Frontiers in Behavioral Neuroscience
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis
- (2013) Camilo de la Fuente-Sandoval et al. JAMA Psychiatry
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies
- (2012) Ana D. Stan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- d-serine and schizophrenia: an update
- (2012) Emerson A Nunes et al. Expert Review of Neurotherapeutics
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins
- (2012) Andrea de Bartolomeis et al. MOLECULAR NEUROBIOLOGY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- Prenatal NMDA Receptor Antagonism Impaired Proliferation of Neuronal Progenitor, Leading to Fewer Glutamatergic Neurons in the Prefrontal Cortex
- (2012) Kazuya Toriumi et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
- (2012) Natalie Matosin et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
- (2012) A. de Bartolomeis et al. PSYCHOPHARMACOLOGY
- Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?
- (2012) D. C. Javitt SCHIZOPHRENIA BULLETIN
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole
- (2012) T Ishima et al. Translational Psychiatry
- 5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons
- (2011) L. Llado-Pelfort et al. CEREBRAL CORTEX
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Schizophrenia as a disorder of disconnectivity
- (2011) Andrea Schmitt et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Performance Improvement CME: Long-Term Treatment of Bipolar Disorder
- (2011) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence
- (2011) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801
- (2011) Nicole L. Roenker et al. NEUROSCIENCE LETTERS
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia
- (2011) Tamara Romón et al. PSYCHOPHARMACOLOGY
- Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain
- (2011) Nina Segnitz et al. PSYCHOPHARMACOLOGY
- Early Life Programming and Neurodevelopmental Disorders
- (2010) Tracy L. Bale et al. BIOLOGICAL PSYCHIATRY
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
- (2010) Xavier Lopez-Gil et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex
- (2010) Keiko Ohoyama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Systematic Review of Aripiprazole—Dose, Plasma Concentration, Receptor Occupancy, and Response
- (2010) Anna Sparshatt et al. JOURNAL OF CLINICAL PSYCHIATRY
- Fluoxetine treatment induces EAAT2 expression in rat brain
- (2010) M. Zink et al. JOURNAL OF NEURAL TRANSMISSION
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem Study
- (2010) Monika Vrajová et al. NEUROCHEMICAL RESEARCH
- Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat
- (2010) Trisha A. Jenkins et al. NEUROSCIENCE LETTERS
- Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP
- (2010) Mirjana Carli et al. PSYCHOPHARMACOLOGY
- Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex
- (2010) Mirjana Carli et al. PSYCHOPHARMACOLOGY
- Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats—A possible model for schizophrenia
- (2009) Paul Christian Baier et al. BEHAVIOURAL BRAIN RESEARCH
- Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801
- (2009) Alexandre Seillier et al. BEHAVIOURAL BRAIN RESEARCH
- Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate☆
- (2009) Stephan Bickel et al. BEHAVIOURAL BRAIN RESEARCH
- Neural Circuitry Models of Schizophrenia: Is it Dopamine, GABA, Glutamate, or Something Else?
- (2009) Francine M. Benes BIOLOGICAL PSYCHIATRY
- Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia
- (2009) BKY Bitanihirwe et al. BMC Psychiatry
- Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress
- (2009) Gary E. Duncan et al. BRAIN RESEARCH
- Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
- (2009) S Yamamura et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clozapine, GABAB, and the Treatment of Resistant Schizophrenia
- (2009) Z J Daskalakis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor mapping: architecture of the human cerebral cortex
- (2009) Karl Zilles et al. CURRENT OPINION IN NEUROLOGY
- Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia
- (2009) Andrea Schmitt et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade
- (2009) Teresa Marie du Bois et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia
- (2009) Samantha L. McLean et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Subchronic Effects of Phencyclidine on Dopamine and Serotonin Receptors: Implications for Schizophrenia
- (2009) Yong Kee Choi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancingN-methyl-D-aspartate receptor-mediated synaptic strength
- (2009) Gang Lei et al. JOURNAL OF NEUROCHEMISTRY
- Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist
- (2009) S. Snigdha et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- Mechanism of differential control of NMDA receptor activity by NR2 subunits
- (2009) Marc Gielen et al. NATURE
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- Testing the glutamate hypothesis of schizophrenia
- (2009) Joshua A Gordon NATURE NEUROSCIENCE
- Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats
- (2009) Nina Segnitz et al. NEUROCHEMISTRY INTERNATIONAL
- Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression
- (2009) M. Zink et al. NEUROPHARMACOLOGY
- Cell Type-Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex
- (2009) Huai-Xing Wang et al. NEUROPSYCHOPHARMACOLOGY
- Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia
- (2009) Adam J. Funk et al. NEUROREPORT
- Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review
- (2009) Dragos Inta et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis
- (2009) D. D. Patel et al. PSYCHOLOGICAL MEDICINE
- Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia
- (2009) Gary Gilmour et al. PSYCHOPHARMACOLOGY
- Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex
- (2009) Satoshi Yamamura et al. PSYCHOPHARMACOLOGY
- Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain
- (2009) Frank I. Tarazi et al. SYNAPSE
- Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptors
- (2008) Shikha Snigdha et al. BEHAVIOURAL BRAIN RESEARCH
- Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
- (2008) Herbert Y. Meltzer et al. BEHAVIOURAL BRAIN RESEARCH
- Altered Vesicular Glutamate Transporter Expression in the Anterior Cingulate Cortex in Schizophrenia
- (2008) Akin Oni-Orisan et al. BIOLOGICAL PSYCHIATRY
- Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
- (2008) Rodrigo D. Paz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of risperidone on glutamate receptor subtypes in developing rat brain
- (2008) Yong Kee Choi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine
- (2008) Giorgia Fattorini et al. GLIA
- Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action
- (2008) Xavier López-Gil et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment
- (2008) Julián De Almeida et al. JOURNAL OF NEUROCHEMISTRY
- Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour
- (2008) L Dahan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Computational models of schizophrenia and dopamine modulation in the prefrontal cortex
- (2008) Edmund T. Rolls et al. NATURE REVIEWS NEUROSCIENCE
- Presynaptic NMDA Receptors: Newly Appreciated Roles in Cortical Synaptic Function and Plasticity
- (2008) Rebekah Corlew et al. NEUROSCIENTIST
- Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs
- (2008) H. Homayoun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors
- (2008) Taku Nagai et al. PSYCHOPHARMACOLOGY
- Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
- (2008) T. Walsh et al. SCIENCE
- Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia
- (2008) Tsung-Tsair Yang et al. SYNAPSE
- Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice
- (2007) Juliana V. Leite et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats
- (2007) R.E. Nordquist et al. NEUROPHARMACOLOGY
- Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways
- (2007) Larissa Moutsimilli et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started